CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,757 JPY | -1.14% |
|
-0.50% | -10.95% |
| May. 23 | Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook | RE |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| Sales 2024 * | 1,088B 6.94B | Sales 2025 * | 1,128B 7.19B | Capitalization | 7,827B 49.9B |
|---|---|---|---|---|---|
| Net income 2024 * | 345B 2.2B | Net income 2025 * | 365B 2.32B | EV / Sales 2024 * | 6.46 x |
| Net cash position 2024 * | 795B 5.07B | Net cash position 2025 * | 1,017B 6.48B | EV / Sales 2025 * | 6.04 x |
| P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
21.5
x | Employees | 7,604 |
| Yield 2024 * |
1.77% | Yield 2025 * |
1.85% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | -1.14% | ||
| 1 week | -0.50% | ||
| Current month | -0.50% | ||
| 1 month | -4.57% | ||
| 3 months | -26.08% | ||
| 6 months | -12.57% | ||
| Current year | -10.95% |
1 week
4 700.00
4 872.00
1 month
4 572.005 076.00
Current year
4 572.006 697.00
1 year
3 767.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
902.336 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 14 M€ | +12.67% | ||
| 1.87% | 57 M€ | +19.07% | ||
| 1.53% | 62,153 M€ | +16.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 4,757 | -1.14% | 1,670,800 |
| 24-06-06 | 4,812 | -0.04% | 1,536,700 |
| 24-06-05 | 4,814 | +0.56% | 1,357,100 |
| 24-06-04 | 4,787 | -0.52% | 1,888,600 |
| 24-06-03 | 4,812 | +0.65% | 1,415,700 |
Delayed Quote Japan Exchange, June 07, 2024 at 02:00 am EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
2024-06-26
- Ex-dividend day for interim dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,757
JPY
Average target price
5,932
JPY
Spread / Average Target
+24.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.95% | 50.74B | |
| +45.82% | 754B | |
| +40.95% | 630B | |
| -6.16% | 352B | |
| +19.86% | 331B | |
| +9.32% | 298B | |
| +18.45% | 250B | |
| +11.88% | 217B | |
| -0.78% | 216B | |
| +5.90% | 164B |
- Stock Market
- Equities
- 4519 Stock
